Virtu Financial LLC Invests $74,000 in Phio Pharmaceuticals Corp. (NASDAQ:PHIO)

Virtu Financial LLC bought a new position in shares of Phio Pharmaceuticals Corp. (NASDAQ:PHIO) in the 4th quarter, HoldingsChannel.com reports. The firm bought 40,910 shares of the company’s stock, valued at approximately $74,000.

Analyst Ratings Changes

Separately, HC Wainwright reissued a “buy” rating and set a $4.00 price objective on shares of Phio Pharmaceuticals in a report on Wednesday, February 19th.

Phio Pharmaceuticals Price Performance

NASDAQ PHIO opened at $1.30 on Tuesday. The company has a fifty day moving average of $1.68 and a two-hundred day moving average of $2.40. The company has a market capitalization of $8.95 million, a PE ratio of -0.12 and a beta of 1.28. Phio Pharmaceuticals Corp. has a 1 year low of $1.22 and a 1 year high of $9.79.

Phio Pharmaceuticals Profile

Phio Pharmaceuticals Corp. engages in the development of immuno-oncology therapeutics in the United States. The company is developing PH-762, an INTASYL compound in Phase 1b dose-escalating clinical trials to reduce the expression of cell death protein 1 (PD-1), a protein that inhibits T cells’ ability to kill cancer cells; and PH-762 treated double positive tumor infiltrating lymphocytes, which is in Phase 1 clinical trials to treat advanced melanoma and other advanced solid tumors.